| Literature DB >> 30337914 |
Eveliina Munukka1,2, Juha P Ahtiainen3, Pere Puigbó4, Sirpa Jalkanen1,5, Katja Pahkala6,7, Anniina Keskitalo1,2, Urho M Kujala3, Sami Pietilä8, Maija Hollmén1,5, Laura Elo8, Pentti Huovinen1, Giuseppe D'Auria9, Satu Pekkala3.
Abstract
Recent studies suggest that exercise alters the gut microbiome. We determined whether six-weeks endurance exercise, without changing diet, affected the gut metagenome and systemic metabolites of overweight women. Previously sedentary overweight women (n = 19) underwent a six-weeks endurance exercise intervention, but two were excluded due to antibiotic therapy. The gut microbiota composition and functions were analyzed by 16S rRNA gene amplicon sequencing and metagenomics. Body composition was analyzed with DXA X-ray densitometer and serum metabolomics with NMR metabolomics. Total energy and energy-yielding nutrient intakes were analyzed from food records using Micro-Nutrica software. Serum clinical variables were determined with KONELAB instrument. Soluble Vascular Adhesion Protein 1 (VAP-1) was measured with ELISA and its' enzymatic activity as produced hydrogen peroxide. The exercise intervention was effective, as maximal power and maximum rate of oxygen consumption increased while android fat mass decreased. No changes in diet were observed. Metagenomic analysis revealed taxonomic shifts including an increase in Akkermansia and a decrease in Proteobacteria. These changes were independent of age, weight, fat % as well as energy and fiber intake. Training slightly increased Jaccard distance of genus level β-diversity. Training did not alter the enriched metagenomic pathways, which, according to Bray Curtis dissimilarity analysis, may have been due to that only half of the subjects' microbiomes responded considerably to exercise. Nevertheless, tranining decreased the abundance of several genes including those related to fructose and amino acid metabolism. These metagenomic changes, however, were not translated into major systemic metabolic changes as only two metabolites, phospholipids and cholesterol in large VLDL particles, decreased after exercise. Training also decreased the amine oxidase activity of pro-inflammatory VAP-1, whereas no changes in CRP were detected. All clinical blood variables were within normal range, yet exercise slightly increased glucose and decreased LDL and HDL. In conclusion, exercise training modified the gut microbiome without greatly affecting systemic metabolites or body composition. Based on our data and existing literature, we propose that especially Akkermansia and Proteobacteria are exercise-responsive taxa. Our results warrant the need for further studies in larger cohorts to determine whether exercise types other than endurance exercise also modify the gut metagenome.Entities:
Keywords: cardiovascular effects; exercise intervention; gut microbiota composition; gut microbiota function; systemic metabolites
Year: 2018 PMID: 30337914 PMCID: PMC6178902 DOI: 10.3389/fmicb.2018.02323
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Figure 1The study design, measurements and exercise protocol.
The physical performance before (Pre) and after the 6-weeks non-training control period (Mid) and after the 6-weeks endurance exercise training period (Post) (n = 17).
| VO2max (ml·min−1·kg−1) | 29.8 ± 5.2 | 29.5 ± 5.6 | 32.5 ± 5.4 | <0.001 |
| Power (W) | 182.9 ± 36.0 | 179.5 ± 38.5 | 202.6 ± 36.4 | <0.001 |
| Heart rate (bpm) | 147.1 ± 6.2 | 145.3 ± 10.0 | 138.8 ± 9.8 | <0.001 |
| Blood lactate (mmol·L−1) | 3.0 ± 0.8 | 3.0 ± 0.8 | 2.3 ± 0.7 | <0.001 |
| VO2 (L·min−1) ( | 1.45 ± 0.21 | 1.47 ± 0.24 | 1.45 ± 0.25 | 0.694 |
| RER ( | 1.09 ± 0.07 | 1.15 ± 0.08 | 1.03 ± 0.06 | <0.001 |
| GE (%) ( | 20.9 ± 1.2 | 20.8 ± 1.7 | 21.8 ± 1.9 | 0.054 |
| MIF (kg) | 154.4 ± 27.5 | 154.1 ± 29.9 | 147.8 ± 31.1 | 0.097 |
| VLT (cm) | 2.34 ± 0.42 | 2.39 ± 0.41 | 2.45 ± 0.41 | 0.023 |
VO2max, maximal oxygen uptake; VO2, oxygen uptake; RER, respiratory exchange ratio; GE, gross efficiency; MIF, maximal isometric force of knee extensors; VLT, thickness of vastus lateralis muscle. Statistically significant change (
p < 0.05,
p < 0.01,
p < 0.001) from the baseline (Pre);*Statistically significant change (
p < 0.01,
p < 0.001) from the post-control period (Mid).
Body composition, age and blood pressure before the control period (Pre), after the control/before exercise (Mid) and after the exercise period (Post).
| Age (years) | 36.8 ± 3.9 | 36.8 ± 3.9 | 36.8 ± 3.9 |
| BP syst (mmHg) | 130 ± 12 | 131 ± 12 | 132 ± 12 |
| BP dias (mmHg) | 81 ± 11 | 82 ± 9 | 80 ± 6 |
| Height (cm) | 168.2 ± 6.1 | 168.2 ± 6.0 | 168.1 ± 6.0 |
| WC (cm) | 98.7 ± 13.0 | 100.9 ± 11.7 | 99.3 ± 11.0 |
| Weight (kg) | 90.1 ± 15.7 | 89.9 ± 15.0 | 89.3 ± 15.6 |
| BMI (kg/m2) | 31.8 ± 4.4 | 31.7 ± 4.2 | 31.4 ± 4.1 |
| Android FM (kg) | 3.87 ± 1.42 | 3.84 ± 1.39 | 3.75 ± 1.39 |
| Gynoid FM (kg) | 7.29 ± 1.63 | 7.18 ± 1.56 | 7.09 ± 1.57 |
| Total FM (kg) | 39.46 ± 10.87 | 39.10 ± 10.47 | 38.55 ± 10.59 |
| Total LM (kg) | 46.80 ± 5.31 | 46.94 ± 5.69 | 46.64 ± 5.45 |
| Android fat% | 52.2 ± 5.6 | 52.0 ± 5.8 | 51.8 ± 6.0 |
| Gynoid fat% | 50.2 ± 4.5 | 50.1 ± 4.9 | 49.9 ± 4.7 |
| Total fat% | 43.6 ± 5.4 | 43.4 ± 5.6 | 43.1 ± 5.6 |
| Visceral fat area (cm2) | 122.6 ± 22.6 | 123.1 ± 22.1 | 122.6 ± 22.7 |
BP, blood pressure; syst, systolic; dias, diastolic; WC, waist circumference; BMI, body mass index; FM, fat mass; LM, lean mass. Statistically significant change (
p < 0.01) from the post-control period (Mid).
Clinical characteristics of the fastsing blood samples of the study subjects before the control period (Pre), after the control/before exercise (Mid) and after the exercise period (Post).
| Glucose (mmol/L) | 5.25 ± 0.30 | 5.15 ± 0.30 | 5.35 ± 0.31 |
| HDL (mmol/L) | 1.30 ± 0.34 | 1.38 ± 0.34 | 1.13 ± 0.28 |
| LDL (mmol/L) | 2.60 ± 0.59 | 2.72 ± 0.60 | 2.50 ± 0.56 |
| FFA (mmol/L) | 699.29 ± 355.75 | 403.88 ± 195.87 | 427.24 ± 127.94 |
| Trigly (mmol/L) | 0.95 ± 0.41 | 1.13 ± 0.65 | 1.10 ± 0.51 |
| Insulin (IU/L) | 54.94 ± 28.82 | 77.80 ± 33.99 | 77.32 ± 40.95 |
| HOMA-IR | 12.9 ± 6.8 | 18.1 ± 8.3 | 18.7 ± 10.6 |
FFA, free fatty acids; Trigly, triglycerides; HOMA-IR, homeostatic model assessment of insulin resistance (
p < 0.05,
p < 0.01, ###p < 0.001) from the baseline (Pre); Statistically significant change (
p < 0.01) from the post-control period (Mid).
Total daily energy intake and intake of energy yielding nutrients before control period (Pre), after control/before exercise (Mid) and after exercise period (Post).
| Energy, kcal/day | |||
| Protein, g/day | 88.5 ± 34.7 | 92.1 ± 28.1 | 76.3 ± 21.7 |
| Fat, g/day | 88.4 ± 38.4 | 83.0 ± 75.2 | 75.2 ± 28.7 |
| Carbohydrates, d/day | 229.8 ± 62.6 | 217.2 ± 57.8 | 215.5 ± 70.5 |
| Starch, g/day | 104.6 ± 29.6 | 91.3 ± 22.4 | 104.5 ± 33.4 |
| Sucrose, g/day | 39.3 ± 19.9 | 34.3 ± 19.8 | 36.6 ± 21.7 |
| Fiber, g/day | 19.9 ± 5.0 | 19.3 ± 4.6 | 19.3 ± 7.3 |
| Protein, E% | 16.7 ± 3.8 | 18.4 ± 3.6 | 16.7 ± 2.7 |
| Fat, E% | 36.9 ± 9.8 | 36.5 ± 6.5 | 35.6 ± 5.5 |
| Carbohydrate, E% | 45.1 ± 11.5 | 43.8 ± 7.9 | 46.7 ± 5.3 |
| Starch, E% | 20.7 ± 6.3 | 19.2 ± 4.6 | 22.8 ± 3.4 |
| Sucrose, E% | 7.4 ± 2.8 | 6.5 ± 3.1 | 7.5 ± 2.7 |
| Fiber, g/MJ | 2.3 ± 0.6 | 2.4 ± 0.7 | 2.5 ± 0.7 |
| Bread, g/day | 85.1 ± 32.4 | 84.0 ± 39.9 | 87.2 ± 57.6 |
| Other grain products, g/day | 130.1 ± 68.2 | 117.3 ± 50.0 | 134.7 ± 75.1 |
| Vegetables, g/day | 309.1 ± 133.6 | 306.6 ± 130.3 | 270.7 ± 127.5 |
| Fruits and berries, g/day | 197.3 ± 149.8 | 166.8 ± 114.8 | 182.6 ± 103.8 |
| Fermented milk products g/day | 144.4 ± 126.3 | 157.8 ± 108.8 | 97.1 ± 101.2 |
| Cheeses, g/day | 44.6 ± 27.5 | 39.2 ± 23.6 | 49.1 ± 26.8 |
| Meat, g/day | 143.6 ± 143.2 | 111.4 ± 65.8 | 82.0 ± 51.5 |
| Fish, g/day | 23.0 ± 42.0 | 31.1 ± 34.2 | 14.4 ± 21.1 |
Fourteen subjects completed the food diaries in all time points. kcal, kilocalories; g/day, grams per day; E%, energy percentage calculated as: 9.082 × (g/day divided by kcal/day) × 100 for fat, and as: 4.063 × (g/day divided by kcal/day) × 100 for protein, carbohydrate, starch, sucrose and fiber; g/MJ, grams per megaJoule. Statistically significant change (
p < 0.05) from the post-control period (Mid).
Figure 2The 16S rRNA gene amplicon sequencing failed to show differences in the microbiota composition between the samples collected before the control period (Pre), after the control period/before exercise (Mid) and after the exercise (Post) period. (A) The genus level abundance analyzed with Illumina MiSeq 16S rRNA gene amplicon sequencing show great inter-individual variation that may have caused the lack of significant differences between the samples collected before the control period (Pre, n = 17), after the control period/before exercise (Mid, n = 17) and after the exercise period (Post, n = 17). (B) PCoA plot of the 16S rRNA gene amplicon sequenced samples before the control period (n = 17), after the control/before the exercise period (n = 17) and after the exercise period (n = 17) shows an important inter-individual variation in the exercise responsiveness.
Figure 3The fecal metagenome analysis reveals that exercise causes shifts in the microbiome at taxonomic while no changes in the major functional pathways were detected. (A) The box plots in the figure show phylum, family and genus level abundances before (n = 15) and after (n = 15) the exercise period of the significantly changing gut microbiota according to the metagenome analysis. An increase was detected in Verrucomicrobia, Verrucomicrobiaceae, Bifidobacteriaceae, Akkermansia, Anaerofilum and Dorea while Proteobacteria, Odoribacter and unidentified Desulfovibrionaceae, Porphyromonadaceae and Enterobacteriaceae decreased. (B) In the metagenomes no significant differences in the major KEGG metabolic pathways were detected between the samples before and after exercise according to the analysis performed with Microbiome Analyst. When assessing the metagenome data the samples of two subjects clustered differently and were removed from the final analyses. Therefore, 15 subjects were included in the metagenome analyses.
The dependence of the taxonomic changes in response to exercise training on age, weight, body fat %, android fat %, intake of total energy intake, sucrose and fiber.
| 1.05 (0.94) | 0.65 (0.63) | |||||||||
| 0.03 (0.04) | 0.10 (0.10) | 0.054 | ||||||||
| 0.41 (0.27) | 1.18 (0.27) | 0.198 | 0.179 | 0.194 | 0.184 | 0.275 | 0.356 | 0.289 | ||
| 0.03 (0.04) | 0.10 (0.10) | |||||||||
| 0.03 (0.04) | 0.10 (0.10) | |||||||||
| 0.16 (0.20) | 0.35 (0.47) | 0.099 | 0.054 | 0.099 | 0.159 | |||||
| 0.23 (0.29) | 0.09 (0.10) | 0.059 | 0.055 | 0.056 | 0.087 | 0.081 | 0.067 | |||
| 0.01 (0.02) | 0.00 (0.00) | 0.075 | 0.076 | 0.071 | 0.123 | 0.145 | 0.109 | |||
| 0.10 (0.17) | 0.02 (0.03) | 0.139 | 0.091 | 0.108 | 0.276 | 0.162 | 0.253 | |||
| 0.38 (0.46) | 0.15 (0.16) | 0.059 | 0.079 | |||||||
Crude p-value,
Adjusted (Adj.) for the value before exercise,
Adjusted for change. The statistically significant p-values are highlighted in bold.
Pathway enrichment before and after the exercise training.
| Polyketide sugar unit biosynthesis | 4 | 0.121 | 3 | 0.000103 | 0.0152 |
| Streptomycin biosynthesis | 12 | 0.362 | 3 | 0.00474 | 0.351 |
| Selenocompound metabolism | 15 | 0.452 | 3 | 0.00919 | 0.419 |
| Amino sugar and nucleotide sugar metabolism | 64 | 1.93 | 6 | 0.0113 | 0.419 |
| Glycine, serine and threonine metabolism | 78 | 2.35 | 6 | 0.0279 | 0.496 |
| Thiamine metabolism | 23 | 0.693 | 3 | 0.0301 | 0.496 |
| Secondary bile acid biosynthesis | 1 | 0.0301 | 1 | 0.0301 | 0.496 |
| Biosynthesis of ansamycins | 1 | 0.0301 | 1 | 0.0301 | 0.496 |
| Biosynthesis of vancomycin group antibiotics | 1 | 0.0301 | 1 | 0.0301 | 0.496 |
FDR, p-value corrected for multiple comparison with Benjamini-Hochberg procedure.
Changes in the abundance of the metabolic genes in response to the exercise training.
| 7-keto-8-aminopelargonate synthetase or related enzyme | Biotin synthesis, ec00780 | −73.197 | 5.106 | 0.047 |
| FAD synthase | Riboflavin synthesis, ec00740 | −45.091 | 7.474 | 0.023 |
| Transcriptional regulators containing an AAA-type ATPase domain and a DNA-binding domain | ATPases Associated with diverse cellular Activities | −115.417 | 6.222 | 0.030 |
| Aspartate ammonialyase | Alanine, Aspartate and Glutamate metabolism (ec00250) | −44.917 | 5.085 | 0.048 |
| Cytochrome bd-type quinol oxidase, subunit 1 | Terminal oxidase that produces a proton motive force, Oxidative phosphorylation (syne00190) | −36.379 | 5.238 | 0.043 |
| K+-transporting ATPase, A chain | High affinity ATP-driven K+ transport system, Signal transduction (ko02020) | −43.356 | 5.130 | 0.047 |
| Uncharacterized membrane protein YbjE, DUF340 family | DUF340 family includes lysine exporter LysO (YbjE) | −33.833 | 7.441 | 0.020 |
| Transcriptional regulator of aromatic amino acids metabolism | Regulation of aromatic amino acids metabolism (map01230?) | −130.106 | 5.852 | 0.039 |
| Transcriptional regulator of acetoin/glycerol metabolism | Activation of acetoin/glycerol metabolism | −136.894 | 5.130 | 0.047 |
| Transcriptional regulator containing PAS, AAA-type ATPase, and DNA-binding Fis domains | Regulation of transcription by ATPase and DNA and protein or ligand binding | −167.189 | 6.203 | 0.030 |
| ABC-type cobalamin transport system, permease component | B12 vitamin-derivative cobalamin transport system (cx02010) | −34.583 | 4.822 | 0.050 |
| L-rhamnose isomerase | Fructose and mannose metabolism (ec00051) | −54.091 | 5.798 | 0.039 |
| Uncharacterized protein YqfA, UPF0365 family | Predicted inner membrane oxidoreductase | −65.030 | 5.490 | 0.041 |
Figure 4Exercise training increases the variability of the functional genes but only half of the subjects microbiomes respond to exercise. (A) PCoA plot of the functional genes shows that the samples before (n = 15) and after (n = 15) the exercise cluster closely together indicating their similarity. The first component explains 39.3% and the second 11.5% of the variability. (B) The Correspondence analysis of the functional genes shows that the samples before the exercise are less variable (more close to the centroid) than the samples after the exercise training indicating that the exercise has caused shifts in the gene abundances. (C) The Bray Curtis dissimilarity analysis shows that only approximately half of the subjects microbiomes have considerably responded to the exercise training, i.e., have Bray Curtis index close to 0.8.
Figure 5The cardiovascular and inflammatory changes in response to exercise. (A) After the exercise period (n = 17) the phospholipids (PL) and cholesterol (C) in large (L) VLDL particles were decreased compared to the samples before exercise (n = 17) as determined with NMR metabolomics. (B) The Correspondence analysis of the metabolites shows inter-individual variation in the metabolites and different clustering of the samples before (n = 17) and after (n = 17) the exercise (on left), and moreover, the samples of each subject before and after the exercise tend to cluster together (on right) indicating no gross changes in metabolites in response to exercise. (C) No differences in serum CRP levels were detected between the time points. After the exercise period (n = 17) VAP-1 enzyme activity (SSAO) decreased but no changes in VAP-1 protein concentration were observed. (D) After the exercise period (Post, n = 17) TLR5 mRNA increased but no changes in TLR4 were observed compared to the samples before the control period (Pre, n = 17) and after the control/before exercise (Mid, n = 17).
Figure 6The associations of the gut microbiota with body composition before the exercise period. The significant associations are marked with asterisks (*). The numeric colored scale bar represents the Spearman correlation coefficients.